Pharmaessentia Corporation is a biopharmaceutical company based in Taipei, Taiwan, specializing in the development and commercialization of innovative therapies for hematologic diseases. The company focuses on research and technology in biologics, particularly in the areas of monoclonal antibodies and other protein-based therapeutics. Pharmaessentia aims to address unmet medical needs through its commitment to advancing treatment options and improving patient outcomes in the global healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#392 in Taipei

#1,425 in Taiwan

#55,986 in the World

Taipei, Taiwan

Pharmaessentia Corporation

Forward Citations = 4

15 inventors:

Ko-Chung Lin (7 out of 18 patents)

Chungsun Chien (2 out of 2 patents)

Wensen Li (2 out of 2 patents)

4. Christoph Klade (2 out of 2 patents)

5. Oleh Zagrijtschuk (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pharmaessentia Corporation. Retrieved from https://idiyas.com/company/pharmaessentia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]